The big patient-centricity payoff for pharma is its relationship with patient advocacy groups that are recruited to lobby Congress, local governments and the FDA.
Drug industry CEOs are busy talking publicly about drug prices, taxes, innovations, and other issues that need defending. Their arguments are highlighted in this article.
This article documents the concerns about the risks of drug sales reps as well as the benefits to physicians.
Welcome to Vol. 16, Issue No. 1 (January 2016) of Pharma Marketing News. This issue focuses on pharma corporate Facebook pages and pharma innovation initiatives.
This article provide a glimpse into what the top 10 drug companies are doing on Facebook.
The Pharma Digital Health Accelerator Club: Companies Leading the Way Implementing Disruptive Innovations
This article features several examples of what the pharmaceutical industry is doing to implement disruptive digital innovations that help them manage clinical trials, improve their products, and support healthcare professionals and patients.